Meta-analysis of multitreatment studies

Medical Decision Making

Volumn 18, Issue 1, 1998, Pages 37-43

  Hasselblad, Vic ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Meta analysis; Multiple treatment studies; Random effects models

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; METOPROLOL; NADOLOL; PROPRANOLOL; TIMOLOL;

ALGORITHM; MAXIMUM LIKELIHOOD METHOD; META ANALYSIS; MODEL; REGRESSION ANALYSIS; REVIEW; RISK;

ADRENERGIC BETA-AGONISTS; ANGINA, UNSTABLE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; LOGISTIC MODELS; META-ANALYSIS; MIGRAINE DISORDERS; ODDS RATIO; PSYCHOTHERAPY; REGRESSION ANALYSIS; RESEARCH DESIGN; SMOKING CESSATION;

EID: 0031961926     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9801800110     Document Type: Review

References (62)

1. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
2. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
3. Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline No. 10, AHCPR Publication No. 94-0602. Rockville, MD: Agency for Health Care Policy and Research, National Heart, Lung, and Blood Institute, 1994.
4. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319: 1105-11.
5. Wallentin LC. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. J Am Coll Cardiol. 1991;18:1587-93.
6. Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet. 1981;1:1225-8.
7. EGRET Reference Manual, Revision 4. Seattle, WA: Statistics and Epidemiology Research Corporation, 1993.
8. Crump KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol. 1984;4:854-71.
9. DerSimonian R, Laird N. Meta analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
10. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando, FL: Academic Press, 1985.
11. Fiore MC, Bailey WC, Choen SJ, et al. Smoking Cessation. Clinical Practice Guideline No. 18. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; AHCPR Publication No. 96-0692, April 1996.
12. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.
13. Roscnthal R, Rubin D. Combining results from independent studies. Psychol Bull. 1979;85:185-93.
14. Glass G. Summarizing effect sizes. In: Rosenthal R (ed). New Directions for Methodology of Social and Behavioral Science: Quantitative Assessment of Research Domains. San Francisco, CA: Jossey-Bass, 1980.
15. Hedges LV. Meta-analysis. J Educ Stat. 1992;17:279-96.
16. Rosenthal R. Meta-analytic procedures for social research. Beverly Hills, CA: Sage Publications, 1984.
17. Glesser LJ, Olkin I. Stochastically dependent effect sizes. In: Cooper H, Hedges LV (eds). The Handbook of Research Synthesis. Troy, NY: Russell Stage Foundation, 1994.
18. Hasselblad V. Numerical techniques in distribution fitting. Comput Sci Stat. 1994;26:217-21.
19. Hasselblad V, Hedges L. Meta-analysis of diagnostic tests. Psychometr Bull. 1995;11:167-78.
20. Reid DD, Brett GZ, Hamilton PJS, Jarrett RJ, Keen H, Rose G. Cardiorespiratory disease and diabetes among middle-aged male civil servants. Lancet. 1974;1:469-73.
21. Cottraux JA, Harf R, Boissel JP, Schbath J, Bouvard M, Gillet J. Smoking cessation with behaviour therapy or acupuncture - a controlled study. Behav Res Ther. 1983;21:417-24.
22. Slama K, Redman S, Perkins J, Reid AL, Sanson-Fisher RW. The effectiveness of two smoking cessation programmes for use in general practice: a randomised clinical trial. Br Med J. 1990;300:1707-9.
23. Jamrozik K, Vessey M, Fowler G, Wald N, Parker G, Van Vunakis H. Controlled trial of three different antismoking interventions in general practice. Br Med J. 1984;288:1499-503.
24. Rabkin SW, Boyko E, Shane F, Kaufert J. A randomized trial comparing smoking cessation programs utilizing behavior modifications, health education or hypnosis. Addict Behav. 1984;9:157-73.
25. Decker BD, Evans RG. Efficacy of a minimal contact version of a multimodal smoking cessation program. Addict Behav. 1989;14:487-91.
26. Richmond RL, Austin A, Webster IW. Three year evaluation of a programme by general practitioners to help patients to stop smoking. Br Med J. 1986;292:803-6.
27. Leung JP. Smoking cessation by auricular acupuncture and behavioral therapy. Psychologia Int J Psychol Orient. 1991; 34:177-87.
28. Mothersill KJ, McDowell I, Rosser W. Subject characteristics and long term post-program smoking cessation. Addict Behav. 1988;13:29-36.
29. Langford ER, Thompson EG, Tripp SC. Smoking and health education during pregnancy: evaluation of a program for women in prenatal classes. Can J Public Health. 1983;74:285-9.
30. Gritz ER, Berman BA, Bastani R, Wu M. A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: testing the limits of the public health model. Health Psychol. 1992;11:280-9.
31. Campbell IA, Hansford M, Prescott RJ. Effect of a "stop smoking" booklet on smokers attending for chest radiography: a controlled study. Thorax. 1986;41:369-71.
32. Sanders D, Fowler G, Mant D, Fuller A, Jones L, Marzillier J. Randomized controlled trial of anti-smoking advice by nurses in general practice. JR Coll Gen Pract. 1989;39:273-6.
33. Hilleman DE, Mohiuddin SM, Delcore MG, Lucas BD Jr. Randomized, controlled trial of transdermal clonidine for smoking cessation. Ann Pharmacother. 1993;27:1025-8.
34. Gillams J, Lewith GT, Machin D. Acupuncture and group therapy in stopping smoking. Practitioner. 1984;228:341-4.
35. Mogielnicki RP, Neslin S, Dulac J, Balestra D, Gillie E, Corson J. Tailored media can enhance the success of smoking cessation clinics. J Behav Med. 1986;9:141-61.
36. Page AR, Walters DJ, Schlegel RP, Best JA. Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription. Addict Behav. 1986;11:443-6.
37. Vetter NJ, Ford D. Smoking prevention among people aged 60 and over: a randomized controlled trial. Age Ageing. 1990; 19:164-8.
38. Williams JM, Hall DW. Use of single session hypnosis for smoking cessation. Addict Behav. 1988; 13:205-8.
39. Pallonen UE, Leskinen L, Prochaska JO, Willey CJ, Kaariainen R, Salonen JT. A 2-year self-help smoking cessation manual intervention among middle-aged Finnish men: an application of the transtheoretical model. Prev Med. 1994;23: 507-14.
40. Russell MA, Merriman R, Stapleton J, Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioners' advice against smoking. Br Med J. 1983;287:1782-5.
41. Stewart PJ, Rosser WW. The impact of routine advice on smoking cessation from family physicians. Can Med Assoc J. 1982;126:1051-4.
42. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J. 1979;2:231-5.
43. Kendrick JS, Zahniser SC, Miller N, et al. Integrating smoking cessation into routine public prenatal care: results of the smoking cessation in pregnancy project. Am J Public Health. 1995;85:217-22.
44. Ahuja GK, Verma AK. Propranolol in prophylaxis of migraine. Indian J Med Res. 1985;82:263-5.
45. Andersson PG, Dahl S, Hansen JH, et al. Prophylactic treatment of classical and non-classical migraine with metoprolol - a comparison with placebo. Cephalalgia. 1983;3:207-12.
46. Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand. 1984;69:1-8.
47. Sudilovsky A, Elkind AH, Ryan RE Sr, Saper JR, stern MA, Meyer JH. Comparative efficacy of nadolol and propranolol in the management of migraine. Headache. 1987;27:421-6.
48. Freitag FG, Diamond S. Nadolol and placebo comparison study in the prophylactic treatment of migraine. J Am Osteopath Assoc. 1984;84:343-7.
49. Stellar S, Ahrens SP, Meibohm AR, Reines SA. Migraine prevention with timolol. A double-blind crossover study. JAMA. 1984;252:2576-80.
50. Kangasneimi P, Andersen AH, Andersson PG, et al. Classic migraine: effective prophylaxis with metoprolol. Cephalalgia. 1987;7:231-8.
51. Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia. 1991;11: 37-45.
52. Briggs RS, Millac PA. Timolol in migraine prophylaxis. Headache. 1979;19:379-81.
53. Forssman B, Henriksson KG, Johannsson V, Lindvall L, Lundin H. Propranolol for migraine prophylaxis. Headache. 1976;16:238-45.
54. Kangasneimi P, Hedman C. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia. 1984;4:91-6.
55. Olerud B, Gustavsson CL, Furberg B. Nadolol and propran-olol in migraine management. Headache. 1986;26:490-3.
56. Olsson JE, Behring HC, Forssman B, et al. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand. 1984;70:160-8.
57. Dahlof C. No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs. Cephalalgia. 1987;7,6 suppl:459-60.
58. Pradalier A, Serratrice G, Collard M, et al. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia. 1989;9:247-53.
59. Johnson RH, Hornabrook RW, Lambie DG. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurol Scand. 1986;73:490-2.
60. Steardo L, Bonuso S, Di Stasio E, Marano E. Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide. Acta Neurol (Napoli). 1982;4:196-204.
61. Borgesen SE, Nielsen JL, Moller CE. Prophylactic treatment of migraine with propranolol. A clinical trial. Acta Neurol Scand. 1974;50:651-6.
62. Steiner TJ, Joseph R, Hedman C, Rose FC. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache. 1988;28:15-23.